Geriatrics
News, opinions and meeting coverage in geriatrics.
FDA Blocks Sale of Supplements for Parkinson's and Alzheimer's
WASHINGTON -- The FDA filed a permanent injunction against two Minnesota companies that distributed amino acid products marketed as treatments for Parkinson's disease, Alzheimer's disease, and a number of other neurological disorders.
Sep 16, 2011
Lab Notes: Red Wine Before Radiation and Red Clover for Hair Loss
Red is the color of the day, as components of red wine and red clover lead this week's Lab Notes, but the blues get their turn in the spotlight, too, as depressed people outshine cheerier folks in some elements of decision making.
May 06, 2011
Diet, Exercise Sufficient to Reduce Triglycerides
While cholesterol control is often balanced between statins and lifestyle changes, reducing triglycerides can usually be accomplished with diet and lifestyle changes alone, according to a new scientific statement from the American Heart Association.
Apr 20, 2011
FDA Panel: Keep ECT Devices as High Risk
GAITHERSBURG, Md. -- The FDA should continue to regulate electroconvulsive therapy (ECT) machines as high-risk devices for treating depression and most other conditions for which ECT is typically used, members of the agency's Neurological Devices Advisory Committee agreed.
Jan 28, 2011
Cardiologist Who Revealed Echo Errors Out of a Job
MILWAUKEE -- A cardiologist whose research at a national medical meeting revealed that other doctors at her hospital were misreading a substantial number of diagnostic echocardiograms has been fired by that hospital, the Journal Sentinel and have learned.
Jan 14, 2011
Will Contrave Succeed Where Others Have Failed?
As part of the Year in Review series, reporters are revisiting major news stories and following up with an analysis of the impact of the original report, as well as subsequent news generated by the initial publication. Here's what's happened on the weight-loss drug front this year.
Dec 26, 2010
ACC: Triglycerides Decreased with Rosuvastatin Therapy
ATLANTA -- In a study that specifically scrutinized the effects of statin therapy on triglycerides, researchers said that rosuvastatin (Crestor) significantly reduced the blood lipid that has been linked to coronary artery disease better than placebo.
Mar 15, 2010
ACC: Clopidogrel Black Box Likely to Have Immediate Clinical Impact
ATLANTA -- The FDA's decision to add a black box warning to the label of clopidogrel (Plavix) came without warning to doctors attending the American College of Cardiology meeting here. But getting the word out to more than 13,000 cardiologists gathered in this city not an easy task.
Mar 14, 2010